KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Times Interest Earned (2016 - 2022)

NovoCure (NVCR) has disclosed Times Interest Earned for 9 consecutive years, with -$9.48 as the latest value for Q2 2022.

  • Quarterly Times Interest Earned rose 27.5% to -$9.48 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was -$66.86 through Mar 2023, down 909.94% year-over-year, with the annual reading at -$5.73 for FY2021, 331.66% down from the prior year.
  • Times Interest Earned hit -$9.48 in Q2 2022 for NovoCure, down from -$0.47 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $3.77 in Q3 2020 to a low of -$13.08 in Q2 2021.
  • Historically, Times Interest Earned has averaged -$2.27 across 5 years, with a median of -$1.79 in 2018.
  • Biggest five-year swings in Times Interest Earned: surged 4121.37% in 2020 and later tumbled 1318.08% in 2022.
  • Year by year, Times Interest Earned stood at -$4.01 in 2018, then skyrocketed by 102.19% to $0.09 in 2019, then soared by 4121.37% to $3.7 in 2020, then tumbled by 390.65% to -$10.76 in 2021, then increased by 11.85% to -$9.48 in 2022.
  • Business Quant data shows Times Interest Earned for NVCR at -$9.48 in Q2 2022, -$0.47 in Q1 2022, and -$10.76 in Q4 2021.